NL-OMON28492招募中不适用
One year follow-up in FSHD: biomarkers and outcome measures on the road to therapy
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- Radboudumc
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patient participated in the FSHD-FOCUS 2 study.
- •2. Patient underwent a muscle ultrasound in the FSHD-FOCUS 2 study.
排除标准
- •1. Incapacitated persons will not be included in this study.
- •2. Patient is unable to visit the Radboudumc (for example due to severe physical handicap).
- •Extra exclusion criteria for subgroup:
- •1. Patients who are wheelchair bound. As most of their leg muscles will be mostly fatty infiltrated, the ultrasound measurements are not reliable. Furthermore, they will be unable to complete most of the clinical measurements.
- •2. Patients who have a history of any illness or clinical condition that, in the opinion of the investigator, might confound the results of the measurements (e.g. Parkinson’s disease or a mitochondrial myopathy).
- •3. Patients who are participating in a clinical trial in the which they receive an investigational product that may affect muscle function.
研究者
相似试验
已完成
不适用
One year follow-up in FSHD: biomarkers and outcome measures on the road to therapyFSHD (facioscapulohumeral muscular dystrophy)Landouzy10028396NL-OMON49566Radboud Universitair Medisch Centrum100
已完成
不适用
FSHD Longitudinal Biomarker Preparatory Studyspierziekte10028396FSHDNL-OMON46095Fulcrum Therapeutics6
招募中
不适用
Ten year follow-up in FSHD: the FOCUS-3 studyFSHD (facioscapulohumeral muscular dystrophy)Landouzy Dejerine disease1002839610029317NL-OMON56838Radboud Universitair Medisch Centrum200
招募中
不适用
HD-med: A longitudinal, observational study to assess medication use, medication efficacy and the role of pharmacogenetics in Huntington*s Disease.Huntington's DiseaseHuntington's chorea (outdated terminology)1008362410028037NL-OMON55123eids Universitair Medisch Centrum391
招募中
Unknown
HD-MED: Aiming to personalize drug treatment in Huntington’s DiseaseNL-OMON23607eiden University Medical Center (investigator-initiated)391